✦ LIBER ✦

Mechanisms of resistance to alkylating agents

✍ Scribed by G. Damia; M. D‘Incalci

Book ID: 110258046
Publisher: Springer
Year: 1998
Tongue: English
Weight: 62 KB
Volume: 27
Category: Article
ISSN: 0920-9069
DOI: 10.1023/a:1008060720608

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of DNA repair in the mechanisms of

Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin

✍ P. Calsou; B. Salles 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 918 KB

Mechanisms of action of, and modes of re

Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies

✍ A.G. Hall; M.J. Tilby 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 875 KB

Molecular Mechanism of the Cytotoxic Act

Molecular Mechanism of the Cytotoxic Action of Difunctional Alkylating Agents and of Resistance to this Action

✍ LAWLEY, P. D.; BROOKES, P. 📂 Article 📅 1965 🏛 Nature Publishing Group 🌐 English ⚖ 456 KB

Cross-resistance to alkylating agents in

Cross-resistance to alkylating agents in multiple myeloma

✍ Joan Bladé; Evarist Feliú; Ciril Rozman; Jordi Estapé; Alfredo Millá; Emili Mont 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB

Novel agents to override imatinib resist

Novel agents to override imatinib resistance mechanisms

✍ Asumi Yokota; Shinya Kimura 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

## Abstract Chronic myelogenous leukemia (CML) is a disorder of hematopoietic stem cells that results from the Philadelphia chromosome (Ph) created through translocation of human chromosomes 9 and 22. The resulting Bcr‐Abl fusion protein has constitutively high tyrosine kinase activity that causes

The Fanconi anemia (FA) pathway confers

The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents

✍ Clark C. Chen; Toshiyasu Taniguchi; Alan D’Andrea 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 552 KB